Browsing by Author "Hogg, Evelyn"
Now showing items 1-12 of 12
-
Antiretroviral hair levels, self-reported adherence, and virologic failure in second-line regimen patients in resource-limited settings
Apornpong, Tanakorn et al. | Date Issued: 2021 -
Biomarkers Associated with Death After Initiating Treatment for Tuberculosis and HIV in Patients with Very Low CD4 Cells
Sattler, Fred R. et al. | Date Issued: 2018 -
Brief Report: Sex Differences in Outcomes for Individuals Presenting for Third-Line Antiretroviral Therapy
Godfrey, Catherine et al. | Date Issued: 2020 -
Diverse HIV-1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line ART in Resource Limited Settings
Wallis, Carole L. et al. | Date Issued: 2020 -
Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial
Hosseinipour, Mina C. et al. | Date Issued: 2016 -
Impact of Larger Sputum Volume on Xpert® MTB/RIF Assay Detection of Mycobacterium tuberculosis in Smear-Negative Individuals with Suspected Tuberculosis
Badal-Faesen, Sharlaa et al. | Date Issued: 2017 -
Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance
Salata, Robert A. et al. | Date Issued: 2023 -
Relationship Between Weight, Efavirenz Exposure, and Virologic Suppression in HIV-Infected Patients on Rifampin-Based Tuberculosis Treatment in the AIDS Clinical Trials Group A5221 STRIDE Study
Luetkemeyer, Anne F. et al. | Date Issued: 2013 -
Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study
Grinsztejn, Beatriz et al. | Date Issued: 2019 -
Timing of antiretroviral therapy for HIV-1 infection and tuberculosis
Havlir, Diane V. et al. | Date Issued: 2011